
Sign up to save your podcasts
Or


We discuss the use of a novel oral agent for the treatment of diabetic retinopathy with David R. Lally, MD, Director of Research, New England Retina Consultants, Springfield, MA
By Retina Synthesis4.5
88 ratings
We discuss the use of a novel oral agent for the treatment of diabetic retinopathy with David R. Lally, MD, Director of Research, New England Retina Consultants, Springfield, MA

18 Listeners

2,446 Listeners

112,734 Listeners

673 Listeners

56,473 Listeners

594 Listeners

4 Listeners

11 Listeners

52 Listeners

10 Listeners

18 Listeners

1 Listeners

0 Listeners

710 Listeners